These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8342556)

  • 1. Increase of hemoglobin A2 in human immunodeficiency virus-1-infected patients treated with zidovudine.
    Routy JP; Monte M; Beaulieu R; Toma E; St-Pierre L; Dumont M
    Am J Hematol; 1993 Jun; 43(2):86-90. PubMed ID: 8342556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs.
    Bhagat P; Kaur Sachdeva R; Sharma P; Updesh Singh Sachdeva M; Chhabra S; Sharma A; Das R
    Infect Dis (Lond); 2016 Feb; 48(2):122-6. PubMed ID: 26431373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of various biological markers in HIV 1 infection].
    Serra JE; Pombo V; Côrte-Real R; da Cunha S; Meliço-Silvestre A
    Acta Med Port; 1993 Jan; 6(1):5-9. PubMed ID: 8097351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of zidovudine therapy on CD8+ T cell anti-HIV activity.
    Mackewicz CE; Landay A; Hollander H; Levy JA
    Clin Immunol Immunopathol; 1994 Oct; 73(1):80-7. PubMed ID: 7923920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated hemoglobin A2 as a marker for β-thalassemia trait in pregnant women.
    Ou Z; Li Q; Liu W; Sun X
    Tohoku J Exp Med; 2011 Mar; 223(3):223-6. PubMed ID: 21403433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
    Mohri H; Singh MK; Ching WT; Ho DD
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):25-9. PubMed ID: 7678340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy.
    Smith MS; Koerber KL; Pagano JS
    Leukemia; 1994 Apr; 8 Suppl 1():S179-82. PubMed ID: 8152287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of elevated hemoglobin A2 measured by the CAPILLARYS system.
    Yang Z; Chaffin CH; Easley PL; Thigpen B; Reddy VV
    Am J Clin Pathol; 2009 Jan; 131(1):42-8. PubMed ID: 19095564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.
    Eichinger S; Pabinger I; Hartl H; Stain C; Mayerhofer S; Schweiger C; Kier P; Schwarzinger I; Kyrle PA; Lechner K
    Thromb Haemost; 1990 Aug; 64(1):108-12. PubMed ID: 1980381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher sensitivity of capillary electrophoresis in detecting hemoglobin A2'compared to traditional gel electrophoresis.
    Oleske DA; Huang RS; Dasgupta A; Nguyen A; Wahed A
    Ann Clin Lab Sci; 2014; 44(3):291-3. PubMed ID: 25117100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoreactive erythropoietin in HIV-infected patients.
    Spivak JL; Barnes DC; Fuchs E; Quinn TC
    JAMA; 1989 Jun; 261(21):3104-7. PubMed ID: 2716142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent low plasma levels of HIV-1 in patients on AZT therapy and its implications.
    Camsonne R; Bustany P; Bigot MC; Pottier D; Moulin MA
    Therapie; 1994; 49(2):146-7. PubMed ID: 7817343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Low doses of azidothymidine in the treatment of HIV-1 virus infection].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Rev Invest Clin; 1992; 44(2):161-8. PubMed ID: 1359619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of beta-thalassemia on the basis of HbA2 determination].
    Fortová H; Slavíková V; Musil F; Suttnar J; Brabec V
    Vnitr Lek; 1995 May; 41(5):302-6. PubMed ID: 7653059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a reference system for the IFCC standardization of HbA
    Paleari R; Caruso D; Kaiser P; Arsene CG; Schaeffer-Reiss C; Van Dorsselaer A; Bissé E; Ospina M; De Jesús VR; Wild B; Mosca A;
    Clin Chim Acta; 2017 Apr; 467():21-26. PubMed ID: 27238872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort study.
    Ayele T; Jarso H; Mamo G
    AIDS Res Ther; 2017 Feb; 14(1):5. PubMed ID: 28143541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection and diagnosis of hemoglobin A2' by high-performance liquid chromatography.
    Van Kirk R; Sandhaus LM; Hoyer JD
    Am J Clin Pathol; 2005 May; 123(5):657-61. PubMed ID: 15981805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.